AI Visibility Scorecard
sentrycd19.com · Healthcare
Borderline visible. AI bots can crawl Leukemia and Lymphoma Clinical Study, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 2 times
Claude
#786,329 of 924,109 in Healthcare for AI visibility
0
AI Naming Predictability
iRarely named · 0/100
More likely to be named than 46% of Healthcare companies
4
AEO Visibility
iNear-invisible · 3.5/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
Leukemia and Lymphoma Clinical Study describes itself simply: "Currently recruiting. A clinical study for adults with leukemia and lymphoma. You or a loved one may be eligible for this study, which is evaluating if an investigational...." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 3.5 out of 10.
Under the hood there is a readable heading structure and substantial page content, but the score is capped by what is missing: structured data describing the business, an llms.txt file, a sitemap.
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.5/10, Leukemia and Lymphoma Clinical Study is crawlable but under-signaled - fixable, and the signals above are where to start.
Has your leukemia or lymphoma returned after treatment or not responded to treatment?
If you or a loved one has leukemia or lymphoma that has come back or hasn’t responded to treatment, you may be eligible to participate in the SENTRY-CD19 study. See if you may qualifyWhat are cD19-positive leukemias And lymphomas?The SENTRY-CD19 study is evaluating a potential new treatment for CD19-positive leukemia and lymphoma.
Have Questions?
At PatientWing, we’re here to support you. You can email, text, call or fill out the form with any questions.
Is this your brand?
The exact fixes for Leukemia and Lymphoma Clinical Study
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Leukemia and Lymphoma Clinical Study.
Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/sentrycd19
Cite this score: Engagemii (2026). "AEO Score for Leukemia and Lymphoma Clinical Study." Retrieved from https://engagemii.com/aeo/brands/sentrycd19
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform